Cite
HARVARD Citation
Cui, Q. et al. (2022). Anlotinib in recurrent or metastatic endometrial cancer. International journal of gynecological cancer. 32 (9), pp. 1147-1152. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cui, Q. et al. (2022). Anlotinib in recurrent or metastatic endometrial cancer. International journal of gynecological cancer. 32 (9), pp. 1147-1152. [Online].